Literature DB >> 25197147

A likelihood estimation of HIV incidence incorporating information on past prevalence.

Lesego Gabaitiri1, Henry G Mwambi2, Stephen W Lagakos3, Marcello Pagano3.   

Abstract

SUMMARY: The prevalence and incidence of an epidemic are basic characteristics that are essential for monitoring its impact, determining public health priorities, assessing the effect of interventions, and for planning purposes. A direct approach for estimating incidence is to undertake a longitudinal cohort study where a representative sample of disease free individuals are followed for a specified period of time and new cases of infection are observed and recorded. This approach is expensive, time consuming and prone to bias due to loss-to-follow-up. An alternative approach is to estimate incidence from cross sectional surveys using biomarkers to identify persons recently infected as in (Brookmeyer and Quinn, 1995; Janssen et al., 1998). This paper builds on the work of Janssen et al. (1998) and extends the theoretical framework proposed by Balasubramanian and Lagakos (2010) by incorporating information on past prevalence and deriving maximum likelihood estimators of incidence. The performance of the proposed method is evaluated through a simulation study, and its use is illustrated using data from the Botswana AIDS Impact (BAIS) III survey of 2008.

Entities:  

Keywords:  Cohort studies; Cross sectional surveys; HIV incidence; Maximum likelihood; previous prevalence

Year:  2013        PMID: 25197147      PMCID: PMC4156321     

Source DB:  PubMed          Journal:  S Afr Stat J        ISSN: 0038-271X


  19 in total

1.  Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay.

Authors:  John W Hargrove; Jean H Humphrey; Kuda Mutasa; Bharat S Parekh; J Steve McDougal; Robert Ntozini; Henry Chidawanyika; Lawrence H Moulton; Brian Ward; Kusum Nathoo; Peter J Iliff; Ekkehard Kopp
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

2.  Relating recent infection prevalence to incidence with a sub-population of assay non-progressors.

Authors:  Thomas Andrew McWalter; Alex Welte
Journal:  J Math Biol       Date:  2009-07-25       Impact factor: 2.259

3.  Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.

Authors:  Francis Barin; Laurence Meyer; Rémi Lancar; Christiane Deveau; Myriam Gharib; Anne Laporte; Jean-Claude Desenclos; Dominique Costagliola
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Designing a genome-based HIV incidence assay with high sensitivity and specificity.

Authors:  Sung Yong Park; Tanzy M T Love; Jeremy Nelson; Sally W Thurston; Alan S Perelson; Ha Youn Lee
Journal:  AIDS       Date:  2011-10-23       Impact factor: 4.177

5.  Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes.

Authors:  A Chawla; G Murphy; C Donnelly; C L Booth; M Johnson; J V Parry; A Phillips; A M Geretti
Journal:  J Clin Microbiol       Date:  2006-12-06       Impact factor: 5.948

6.  Estimating HIV incidence based on combined prevalence testing.

Authors:  Raji Balasubramanian; Stephen W Lagakos
Journal:  Biometrics       Date:  2009-04-13       Impact factor: 2.571

7.  The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates.

Authors:  R Brookmeyer; T Quinn; M Shepherd; S Mehendale; J Rodrigues; R Bollinger
Journal:  Am J Epidemiol       Date:  1995-10-01       Impact factor: 4.897

8.  Augmented cross-sectional prevalence testing for estimating HIV incidence.

Authors:  Rui Wang; Stephen W Lagakos
Journal:  Biometrics       Date:  2010-09       Impact factor: 2.571

9.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

Authors:  R S Janssen; G A Satten; S L Stramer; B D Rawal; T R O'Brien; B J Weiblen; F M Hecht; N Jack; F R Cleghorn; J O Kahn; M A Chesney; M P Busch
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272

10.  Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection.

Authors:  Vladimir Novitsky; Rui Wang; Lemme Kebaabetswe; Jamieson Greenwald; Raabya Rossenkhan; Sikhulile Moyo; Rosemary Musonda; Elias Woldegabriel; Stephen Lagakos; M Essex
Journal:  J Acquir Immune Defic Syndr       Date:  2009-10-01       Impact factor: 3.731

View more
  1 in total

1.  Efficient estimation of human immunodeficiency virus incidence rate using a pooled cross-sectional cohort study design.

Authors:  Kesaobaka Molebatsi; Lesego Gabaitiri; Lucky Mokgatlhe; Sikhulile Moyo; Simani Gaseitsiwe; Kathleen E Wirth; Victor DeGruttola; Eric Tchetgen Tchetgen
Journal:  Stat Med       Date:  2020-09-01       Impact factor: 2.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.